This action is the main reason I'm sticking with Bot till the end. If the FDA does not take the type action as it has done with Curaleaf, then there is a chance BOT's value is undermined by the public's impression OTC products without approval, are acceptable and are just as effective and a cheaper alternative, hence reducing sales of approved products. Great News to see this article IMO. Thanks for posting!
The Green Fund-Best pot stocks 2019, page-41
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
-0.025(7.25%) |
Mkt cap ! $581.5M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 35.0¢ | 32.0¢ | $1.732M | 5.231M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 413440 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 46819 | 2 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |